Timely drug delivery from controlled-release devices: dynamic analysis and novel design concepts
Related Experiment Video
Updated: Jun 27, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
1Otto H. York Department of Chemical, New Jersey Institute of Technology, Newark, NJ 07029, USA. laurent.simon@njit.edu
Abstract:
Design tools are provided to assist in the development of drug-release devices that can control the time to establish a steady-state flux in addition to a desired delivery rate. In this contribution, the primary focus is placed on passive, heat-aided, and electrically assisted transport through planar membranes. Approximate analytical methods, that describe process dynamics, were applied to appropriate mathematical models to derive relationships between the system properties (e.g., diffusion coefficient, temperature and voltage potential) and the flux response time. Three case studies were investigated to illustrate the theoretical results. A steady-state benzocaine flux through ethylene-vinyl acetate membranes was achieved in 40min as predicted by a first-moment time constant approach. It took 5h and 45min to reach a constant delivery rate of amitriptyline HCl across human skin for a donor cell concentration of 0.032M and an electric current of 0.4mA/cm(2). Based on the upper limit and range estimates of the first eigenvalue, the onset of steady-state flux occurred between 3.4 and 3.5min when the donor and receiver cells were maintained at 47 and 37 degrees C, respectively. These predictions were confirmed by simulation, experimental evidence and graphical examination of drug-release data.
Related Concept Videos
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Drug Release Characteristics
Modified-Release Drug Delivery Systems: Influencing Factors
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed I

